MMP26: A Protein with Potential as A Drug Target and Biomarker

Target Name: MMP26

NCBI ID: G56547

MMP26

MMP26: A Protein with Potential as A Drug Target and Biomarker

MMP26 is a protein that is expressed in various tissues throughout the body, including the brain, lungs, heart, kidneys, and gastrointestinal tract. It is a member of theMatrix/transformer family of proteins, which are involved in the regulation of cell signaling pathways. MMP26 has been shown to play a role in the regulation of cellular processes that are important for various physiological processes, including cell adhesion, migration, and invasion.

One of the unique features of MMP26 is its ability to interact with multiple signaling pathways, including the TGF-β pathway, the FGFR pathway, and the NF-kappa-B pathway. This interactivity makes MMP26 an attractive drug target for researchers to study the role of these pathways in various biological processes.

MMP26 has also been shown to be involved in the regulation of cellular responses to stimuli, including the regulation of pain perception and the modulation of neurotransmitter release. This involvement makes MMP26 a potential drug target for the treatment of pain disorders and neuropsychiatric disorders.

In addition to its potential drug-target properties, MMP26 has also been shown to have potential as a biomarker for various diseases. For example, MMP26 has been shown to be decreased in individuals with Alzheimer's disease, a leading cause of dementia. This decrease in MMP26 levels has been associated with an increased risk of developing Alzheimer's disease. Therefore, MMP26 may be a useful biomarker for the diagnosis and treatment of Alzheimer's disease.

Another example of MMP26's potential as a biomarker is its decreased levels in individuals with cancer. MMP26 has been shown to be involved in the regulation of cell signaling pathways, including the regulation of cell adhesion and migration. Therefore, MMP26 may be a useful biomarker for the diagnosis and treatment of certain types of cancer.

In addition to its potential use as a drug target and biomarker, MMP26 is also of interest as a potential therapeutic agent. For example, MMP26 has been shown to be involved in the regulation of cellular processes that are important for the development and progression of various diseases, including cancer. Therefore, MMP26 may be a useful therapeutic agent for the treatment of these diseases.

In conclusion, MMP26 is a protein that has been shown to play a role in various cellular processes that are important for the development and progression of various diseases. Its potential as a drug target and biomarker make it an attractive target for researchers to study the role of MMP26 in these processes. Further research is needed to fully understand the role of MMP26 in these processes and its potential as a therapeutic agent.

Protein Name: Matrix Metallopeptidase 26

Functions: May hydrolyze collagen type IV, fibronectin, fibrinogen, beta-casein, type I gelatin and alpha-1 proteinase inhibitor. Is also able to activate progelatinase B

The "MMP26 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MMP26 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets